Medical and Pharmaceutical Industry - Market Research Report

  The global medical image analysis software market size is expected to reach USD 5.48 billion by 2030, expanding at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs the demand for medical image analysis software. The high growth is majorly attributed to a rise in the usage and uptake of image analysis solutions for diagnosis. Furthermore, the rising demand for medical image analysis software is being driven by the increased use of imaging equipment due to the rising prevalence of chronic diseases and developing applications of computer-aided diagnosis. According to data by the National Health Council, in 2020, around 133 million Americans were affected by chronic diseases, accounting for more than 40% of the country’s total population. Thus, increasing cases of chronic diseases lead to an upsurge in the usage of medical imaging techniques...

The U.S. intravenous immunoglobulin market size is expected to reach USD 10.42 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 7.7% during the forecast period, driven by the rising prevalence of primary and acquired immunodeficiency diseases such as congenital AIDS, and increased adoption of IVIG therapy. There are over 350 chronic disorders that are categorized as PIDD, and medical therapies are available for over 50% of these conditions. In addition, drugs for the treatment of the diseases are covered under Medicare Part B and reimbursement is available for home settings as well as physicians' offices, which is anticipated to drive treatment adoption. The unmet need is high in patients, which provides immense growth opportunities for players. For instance, the treatment cost for IVIG is high, making it hard for patients to afford it without insurance or Medicare coverage. Thus, the entry of novel low-cost IVIG treatmen...

  The global high potency active pharmaceutical ingredients market size is expected to reach USD 40.66 billion by 2030 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the HPAPI market is attributed to rising incidence of cancer, growing targeted therapies, and increasing application of high potency active pharmaceutical ingredients (HPAPI) in treating target diseases. Rising prevalence of cancer is expected to be a major factor. According to the WHO, cancer is the second leading cause of death, accounting for around 9.9 million deaths in 2020. Due to the growing number of people who contract the disease, cancer is regarded as one of the major health risks. The CDC states that factors such as smoking, obesity, alcohol use, and UV radiation exposure are risk factors for cancer since they contribute to the overall burden of the illness. With limited treatment options and s...

  The global ultraviolet disinfection equipment market size is anticipated to reach USD 6.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.0% from 2024 to 2030. The growth of the market is largely driven by the increased government initiatives along with the rising demand for ultraviolet (UV) disinfection equipment from healthcare organizations. According to the WHO, for every hundred patients hospitalized at any given time, ten in developing countries and seven in developed countries will acquire at least one HAI. The infection rate is significantly higher in middle- and low-income countries, particularly in patients admitted to intensive care units or neonates, thus driving the industry growth. Increasing awareness regarding the importance of water quality combined with the increasing suite of regulations has increased the need for a higher degree of disinfection and reduction in byproducts, thus a large nu...

  The global sepsis diagnostics market size is expected to reach USD 1.82 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2024 to 2030. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response to pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads to prolonged hospitalization. According to the WHO, around 30 million people are estimated to be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million ...

  The U.S. medical device outsourcing market size is expected to reach USD 58.5 billion by 2030, expanding at a CAGR of 11.5% during the forecast period, according to a new report by Grand View Research, Inc. This market is growing as a result of increased offshore trends, a rise in demand for high-tech medical devices, and stringent regulation for medical devices in the U.S. The medical device industry has always been highly competitive, and categories such as coronary stents, orthopedic devices, and wound care are moving toward maturity. As high-impact scientific innovation in the above categories is difficult to achieve and is a time-consuming process, smaller companies are gaining market share by offering low prices and introducing innovative business models. Due to the convergence of mounting challenges and changing market dynamics, medical device manufacturers are likely to opt for outsourcing business models to reduce costs, manage business risks, and improve service deliver...

  The global tissue diagnostics market size is expected to reach USD 14.03 billion by 2030, registering a CAGR of 8.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth. The use of digital slides has significantly increased in recent years, owing to its associated benefits including flexible magnification and remote access to slides. The growing emphasis on precision medicine is supported by several organizations & companies in the U.S., which is expected to contribute to the market growth. Additionally, companies are supporting the development of precision medicine with novel oncology solutions. For instance, in May 2020, QIAGEN launched new oncology solutions,...